Project Grant 2503896
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$360K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Tuscaloosa, AL 35401, USA
Similar Awards
This $487,795 award from the National Science Foundation (NSF) Engineering grant program (CFDA 47.041) supports Arizona State University in developing innovative ex vivo models of the tumor microenvironment (TME). The project aims to mechanistically understand how biophysical cues and signaling between stromal and immune cells contribute to the transition of tumor cells into an invasive phenotype, as well as explore how stromal cell function induces pathway signatures in tumor cells leading to...
This National Science Foundation Project Grant of $299,785 will fund research into the integrated effects of mechanical and biochemical factors on breast tumor invasion and metastasis. Awarded on September 1, 2022 under the Engineering program (CFDA 47.041), the grant supports a collaborative research project led by the University of Michigan from September 1, 2022 through August 31, 2025. Specifically, the research team will develop quantitative imaging biosensors and tissue-engineered breast...
The University of Pittsburgh has been awarded a $438,137 Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) to develop a microfluidic technology to model the interactions between macrophages and epithelial cells in a 3D environment under hypoxic conditions. The goal is to advance the fundamental understanding of how oxygen levels impact key cellular processes in macrophages, such as migration and proinflammatory cytokine production. This research will also...
This $353,843 Project Grant award from the National Science Foundation (NSF) under the Engineering program (CFDA 47.041) supports the development of programmable and dynamically-responsive bacterial therapeutics for cancer immunotherapy. The key objectives are to create a biosensing system in E. coli bacteria to recognize extracellular cancer antigens and deliver toxic, immunostimulatory payloads, while also engineering bacteria with improved tumor colonization capabilities for safe, systemic...
This $895,779 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) aims to advance the science of brain metastases from HER2-positive breast cancer. The key products and services to be delivered under this 7-year grant include: Understanding the fundamental biology and genetic risk factors of HER2-positive breast cancer metastases to the brain through patient tissue-based research. Developing real-time visualization techniques to track cancer cells and...
This federal Project Grant award, funded by the National Science Foundation's Engineering program (CFDA 47.041), supports research to grow three-dimensional cancer-myeloid organoids on the International Space Station (ISS) in order to better mimic brain tumor formation and study interactions between cancer and immune cells. The $400,000 award, with a project period from September 2024 to August 2027, will first generate "flight-ready" organoid seeds from various cancer and immune...
The National Science Foundation (NSF) awarded a $125,731 Project Grant to the Kennesaw State University Research And Service Foundation, Inc. (KSU R&SF) on October 1, 2023. The award is funded through the NSF's Engineering program (CFDA 47.041), which supports a wide range of research and development activities to advance engineering knowledge and capabilities. This particular award will tackle the challenge of exploring, analyzing, and interpreting the complex interactions in the tumor...
This $429,114 federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) will fund the development and validation of a first-of-its-kind multi-tissue on-a-chip breast-skin platform. The platform will feature integrated blood and lymphatic vasculature to study the spatial and temporal processes of lymphovascular space invasion (LVSI), dermal lymphatic invasion (DLI), and skin metastasis in breast cancer. The central hypothesis is that the cross-talk...
This National Science Foundation (NSF) Engineering program (CFDA 47.041) Project Grant award of $575,000 to the New Jersey Institute of Technology (NJIT) will study how the microstructure and interstitial fluid pressure gradient impact cell invasion in a bioprinted tumor-on-a-chip model. The key products and services to be delivered include: Developing a 3D bioprinted tumor spheroid microtissue model with controlled microstructure and tunable fluid-induced pressure. This will involve...
This National Science Foundation Project Grant of $606,649 will support the development of an engineered cyber-physical system combining advanced biological models and artificial intelligence methods to enable precision medicine for cancer treatment. Awarded under the Computer and Information Science and Engineering program, the funding will be used by Brigham and Women's Hospital and its parent organization Partners Healthcare System from October 2022 to September 2025. Specifically, the...